Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Ovarian_Cancer
|
gptkbp:can_lead_to |
Lymphadenopathy
Ascites Peritoneal carcinomatosis |
gptkbp:caused_by |
gptkb:Nausea
Diarrhea Fatigue Weight loss Constipation |
gptkbp:end_of_life |
5-year survival rate is approximately 47%
|
gptkbp:has_style |
gptkb:Clear_cell_carcinoma
gptkb:Endometrioid_carcinoma gptkb:Mucinous_carcinoma gptkb:Serous_carcinoma |
https://www.w3.org/2000/01/rdf-schema#label |
Epithelial ovarian cancer
|
gptkbp:is_associated_with |
gptkb:Lynch_syndrome
gptkb:Peutz-Jeghers_syndrome BRC A1 mutation BRC A2 mutation |
gptkbp:is_monitored_by |
Blood tests
Imaging tests Regular follow-up exams |
gptkbp:is_often_used_in |
gptkb:philosopher
African American women Asian women Caucasian women |
gptkbp:is_part_of |
Gynecologic oncology
|
gptkbp:is_related_to |
Environmental factors
Genetic predisposition Hormonal factors |
gptkbp:is_studied_in |
Clinical trials
|
gptkbp:number_of_stages |
Stage I
Stage II Stage III Stage IV |
gptkbp:risk_factor |
gptkb:Endometriosis
Obesity Family history of ovarian cancer Age over 50 |
gptkbp:screenings |
CA-125 blood test
Transvaginal ultrasound |
gptkbp:social_responsibility |
Biopsy
Ultrasound CT scan Pelvic examination |
gptkbp:symptoms |
Pelvic pain
Abdominal bloating Difficulty eating Urinary urgency |
gptkbp:treatment |
gptkb:hospital
gptkb:Cure Chemotherapy Radiation therapy Platinum-based chemotherapy Palliation Taxane chemotherapy |